临床特征 | 细胞核NCL | x2 | P | 细胞膜NCL | x2 | P | |||
低表达 | 高表达 | 低表达 | 高表达 | ||||||
性别 | 男 | 32 | 63 | 2.944 | 0.086 | 45 | 50 | 1.087 | 0.297 |
女 | 41 | 48 | 49 | 40 | |||||
年龄 | ≤65岁 | 36 | 59 | 0.260 | 0.610 | 46 | 49 | 0.559 | 0.455 |
>65岁 | 37 | 52 | 48 | 41 | |||||
肿瘤部位 | 左半结肠 | 39 | 55 | 0.265 | 0.607 | 49 | 45 | 0.083 | 0.773 |
右半结肠 | 34 | 56 | 45 | 45 | |||||
肿瘤大小 | <5 cm | 33 | 39 | 1.875 | 0.171 | 44 | 28 | 4.757 | 0.029 |
≥5 cm | 40 | 72 | 50 | 62 | |||||
大体类型 | 隆起型 | 28 | 46 | 1.368 | 0.505 | 48 | 26 | 9.467 | 0.009 |
溃疡型 | 23 | 40 | 27 | 36 | |||||
浸润型 | 22 | 25 | 19 | 28 | |||||
组织学类型 | 腺癌 | 67 | 101 | 0.035 | 0.852 | 88 | 80 | 1.295 | 0.255 |
其他 | 6 | 10 | 6 | 10 | |||||
脉管侵犯 | 否 | 72 | 101 | 4.572 | 0.032 | 93 | 80 | 8.257 | 0.004 |
是 | 1 | 10 | 1 | 10 | |||||
神经侵犯 | 否 | 72 | 110 | 0.090 | 0.764 | 94 | 88 | 2.112 | 0.146 |
是 | 1 | 1 | 0 | 2 | |||||
T | T1 | 2 | 0 | 9.658 | 0.022 | 2 | 0 | 29.715 | <0.001 |
T2 | 13 | 7 | 18 | 2 | |||||
T3 | 38 | 64 | 58 | 44 | |||||
T4 | 20 | 40 | 16 | 44 | |||||
N | N0 | 62 | 59 | 20.067 | <0.001 | 77 | 44 | 22.328 | <0.001 |
N1 | 9 | 37 | 12 | 34 | |||||
N2 | 2 | 15 | 5 | 12 | |||||
M | M0 | 71 | 105 | 0.752 | 0.386 | 93 | 83 | 4.984 | 0.026 |
M1 | 2 | 6 | 1 | 7 | |||||
TNM分期 | I | 14 | 6 | 24.259 | <0.001 | 20 | 0 | 37.343 | <0.001 |
II | 47 | 50 | 56 | 41 | |||||
III | 10 | 49 | 17 | 42 | |||||
IV | 2 | 6 | 1 | 7 |